Literature DB >> 19331145

Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue.

Kathryn McCarthy1, Christiana Laban, Stephen A Bustin, William Ogunkolade, Sahira Khalaf, Rob Carpenter, Paul J Jenkins.   

Abstract

Vitamin D has anti-proliferative and proapoptotic effects on several cell types, including breast cancer cells. There have been no studies quantifying the expression of the enzyme 25-hydroxyvitamin D-1-alpha-hydroxylase (1alphaOHase), which converts 25-hydroxyvitamin D to its active metabolite, in breast tissue. We performed real-time RT-PCR to quantity 1alphaOHase and vitamin D receptor (VDR) mRNA in samples of breast cancer, adjacent non-cancerous tissue and normal breast tissue. 1alphaOHase and VDR mRNA were universally expressed, however, 1alphaOHase expression was significantly down-regulated in adjacent non-cancerous tissue from women with breast cancer in comparison to individuals without cancer. VDR was also up-regulated in breast tumours. The vitamin D axis expression in the breast suggests a role for its actions in normal tissue homeostasis and breast cancer pathogenesis. The decreased expression of 1alphaOHase in normal tissue from women with breast cancer may be important in their predisposition to the development of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331145

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

Review 1.  Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.

Authors:  J S Adams; M Hewison
Journal:  Arch Biochem Biophys       Date:  2012-03-14       Impact factor: 4.013

2.  DNA methylation-related vitamin D receptor insensitivity in breast cancer.

Authors:  Radharani Marik; Maryjo Fackler; Edward Gabrielson; Martha A Zeiger; Saraswati Sukumar; Vered Stearns; Christopher B Umbricht
Journal:  Cancer Biol Ther       Date:  2010-07-09       Impact factor: 4.742

3.  Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.

Authors:  Tariq Chukir; Yi Liu; Katherine Hoffman; John P Bilezikian; Azeez Farooki
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

4.  1α, 25-Dihydroxyvitamin D regulates hypoxia-inducible factor-1α in untransformed and Harvey-ras transfected breast epithelial cells.

Authors:  Yan Jiang; Wei Zheng; Dorothy Teegarden
Journal:  Cancer Lett       Date:  2010-07-23       Impact factor: 8.679

5.  Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.

Authors:  Isabelle Clinckspoor; Esther Hauben; Lieve Verlinden; Annick Van den Bruel; Lieve Vanwalleghem; Vincent Vander Poorten; Pierre Delaere; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  J Histochem Cytochem       Date:  2012-04-17       Impact factor: 2.479

Review 6.  Function of the vitamin D endocrine system in mammary gland and breast cancer.

Authors:  JoEllen Welsh
Journal:  Mol Cell Endocrinol       Date:  2017-06-01       Impact factor: 4.102

7.  Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

Authors:  Nair Lopes; Bárbara Sousa; Diana Martins; Madalena Gomes; Daniella Vieira; Luiz A Veronese; Fernanda Milanezi; Joana Paredes; José L Costa; Fernando Schmitt
Journal:  BMC Cancer       Date:  2010-09-11       Impact factor: 4.430

Review 8.  The impact of vitamin D in breast cancer: genomics, pathways, metabolism.

Authors:  Carmen J Narvaez; Donald Matthews; Erika LaPorta; Katrina M Simmons; Sarah Beaudin; JoEllen Welsh
Journal:  Front Physiol       Date:  2014-06-13       Impact factor: 4.566

Review 9.  Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis.

Authors:  Julia Höbaus; Ursula Thiem; Doris M Hummel; Enikö Kallay
Journal:  Anticancer Agents Med Chem       Date:  2013-01       Impact factor: 2.505

10.  25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃.

Authors:  Kun-Chun Chiang; Chun-Nan Yeh; Cheng-Cheng Huang; Ta-Sen Yeh; Jong-Hwei S Pang; Jun-Te Hsu; Li-Wei Chen; Sheng-Fong Kuo; Atsushi Kittaka; Tai C Chen; Horng-Heng Juang
Journal:  Int J Mol Sci       Date:  2016-08-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.